102 related articles for article (PubMed ID: 9792041)
1. Liver regeneration, liver cancers and cyclins.
Kitamura T; Watanabe S; Sato N
J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S96-9. PubMed ID: 9792041
[TBL] [Abstract][Full Text] [Related]
2. Liver regeneration, liver cancers and cyclins.
Kitamura T; Watanabe S; Sato N
J Gastroenterol Hepatol; 1998 Sep; 13(S1):S96-S99. PubMed ID: 28976693
[TBL] [Abstract][Full Text] [Related]
3. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
4. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
[TBL] [Abstract][Full Text] [Related]
5. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
6. Irregular regeneration of hepatocytes and development of hepatocellular carcinoma in primary biliary cirrhosis.
Miyakawa H; Fujikawa H; Kikuchi K; Kitazawa E; Kawashima Y
Am J Gastroenterol; 2002 Feb; 97(2):488. PubMed ID: 11866295
[No Abstract] [Full Text] [Related]
7. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
8. [Effects of overexpression of p21WAF1/CIP1 on the malignant phenotype and apoptosis of human hepatocellular carcinoma cells].
Yang F; Wang W
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):99-101. PubMed ID: 11776868
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
10. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly.
Alison MR; Islam S; Lim S
J Pathol; 2009 Jan; 217(2):282-98. PubMed ID: 18991329
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia.
Ganger DR; Hamilton PD; Klos DJ; Jakate S; McChesney L; Fernandez-Pol JA
Cancer Detect Prev; 2001; 25(3):231-6. PubMed ID: 11425264
[TBL] [Abstract][Full Text] [Related]
12. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice.
Shteyer E; Liao Y; Muglia LJ; Hruz PW; Rudnick DA
Hepatology; 2004 Dec; 40(6):1322-32. PubMed ID: 15565660
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stem and progenitor cells in liver diseases and hepatocarcinogenesis.
Heim D; Wege H
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):111-21. PubMed ID: 19305371
[TBL] [Abstract][Full Text] [Related]
14. New epidemiological data on liver oncogenesis.
Kountouras J; Lygidakis NJ
Hepatogastroenterology; 2000; 47(33):855-61. PubMed ID: 10919047
[TBL] [Abstract][Full Text] [Related]
15. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the tyrosine phosphatase early gene of liver regeneration (PRL-1) in cell cycle and in liver regeneration and fibrosis effect of halofuginone.
Gnainsky Y; Spira G; Paizi M; Bruck R; Nagler A; Genina O; Taub R; Halevy O; Pines M
Cell Tissue Res; 2006 Jun; 324(3):385-94. PubMed ID: 16508789
[TBL] [Abstract][Full Text] [Related]
17. Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis.
Tannapfel A; Wittekind C
Virchows Arch; 2002 Apr; 440(4):345-52. PubMed ID: 11956813
[TBL] [Abstract][Full Text] [Related]
18. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration.
Mohammed FF; Pennington CJ; Kassiri Z; Rubin JS; Soloway PD; Ruther U; Edwards DR; Khokha R
Hepatology; 2005 Apr; 41(4):857-67. PubMed ID: 15726641
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
20. Nuclear receptors in regenerating liver and hepatocellular carcinoma.
Vacca M; Degirolamo C; Massafra V; Polimeno L; Mariani-Costantini R; Palasciano G; Moschetta A
Mol Cell Endocrinol; 2013 Apr; 368(1-2):108-19. PubMed ID: 22789748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
